Journals / Retina-Vitreus / 2020 / Cilt: 29 - Sayı: 1

Posterior Segment Effects of Prostaglandin Analogues

Pages
30–34
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

PG analogue therapy should be kept in mind in clinical conditions where choroidal thickness is signifi cant.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Prostaglandin (PG) analogues are commonly used in the treatment of glaucoma.
📊
Key Findings & Data:Materials and Methods: Patients diagnosed with POAG and treated for 1 to 3 years were included in the study.
💡
Conclusion & Impact:PG analogue therapy should be kept in mind in clinical conditions where choroidal thickness is signifi cant.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Purpose: Prostaglandin (PG) analogues are commonly used in the treatment of glaucoma. In this study, we aimed to investigate the posterior segment effects of the drug with long-term use of topical PG analogue monotherapy in patients with the diagnosis of primary open angle glaucoma (POAG). Materials and Methods: Patients diagnosed with POAG and treated for 1 to 3 years were included in the study. A total of 25 patients treated with latanoprost monotherapy formed the 1st group, 25 patients who received dorzolamide timolol combination monotherapy constituted the 2nd group, 25 patients with brimonidine monotherapy formed the 3rd group and 31 healthy volunteers made up the 4th group. Routine ophthalmological examination, intraocular pressure (IOP) measurement and fundus examinations were performed thoroughly. Central macular and choroidal thicknesses were measured by optical coherence tomography (OCT). Results: There was no signifi cant difference in the mean macular thickness between the groups. The mean choroidal thickness was signifi cantly higher in patients using PG analogue than the other groups. None of the patients had intraocular infl ammation or cystoid macular edema (CME). Conclusion: The choroidal thickness was signifi cantly higher in the group receiving topical latanoprost monotherapy than the other groups. None of the patients had CME or infl ammation. PG analogue monotherapy can be used safely in POAG cases. PG analogue therapy should be kept in mind in clinical conditions where choroidal thickness is signifi cant.

🔖

Cite This Article

SINIM, N., KARAKÜÇÜK, S. (2020). Posterior Segment Effects of Prostaglandin Analogues. Retina-Vitreus, Cilt: 29 - Sayı: 1, 30–34. https://ajindex.com/articles/304783

References (14)

  1. Shah R, and Wormald RP. Glaucoma. BMJ Clin. Evid. 2011; 06: 703-710
  2. Fajgenbaum M and Ansari E. Prescribing Trends in a Glaucoma Clinic and Adherence to EGS Guidelines. A Retrospective, Non- Interventional, Single-Center UK Study. Adv Ther. 2017; 34: 2033-2044
  3. Mastropasqua R, Fasanella V, Agnifi li L, Fresina M, Di Staso S, Di Gregorio A, Marchini G. and Ciancaglini M. Advance in the pathogenesis and treatment of normaltension glaucoma. Prog Brain Res. 2015; 221: 213-232
  4. Konstas A.G, Maltezos A.C, Gandi S, Hudgins AC and Stewart WC. Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma. Am. J. Ophthalmol. 1999; 128: 15–20
  5. Parentin F. Granulomatous anterior uveitis associated with bimatoprost: a case report. Ocul Immunol Infl amm 2003; 11: 67–71
  6. Packer., Fine IH, Hoffman RS. Bilateral nongranulomatous anterior uveitis associated with bimatoprost. J Cataract Refract Surg. 2003; 29: 2242–2243
  7. Kroll DM, Schuman JS. Reactivation of herpes simplex virus keratitis after initiating bimatoprost treatment for glaucoma. Am J Ophthalmol 2002; 133:401–403
  8. Artunay O, Senel A, Sengul A, Rasier R, Bahcecioglu H. Central serous chorioretinopathy associated with topical latanoprost therapy. Ocul Immunol Infl amm 2011; 19(6):453–455
  9. Ozdemir H, Karacorlu M, Karacorlu SA. Serous detachment of macula in cystoid macular edema associated with latanoprost. Eur J Ophthalmol. 2008; 18(6):1014
  10. Krishnamurthy R, Senthil S, Garudadri CS. Late postoperative choroidal detachment following an uneventful cataract surgery in a patient on topical latanoprost. BMJ Case Rep. 2015
  11. Sezer T, Altinisik M, Koytak IA, Ozdemir MH. Koroid ve Optik Koherens Tomografi. Turk J Ophthalmol 2016; 46: 30- 37
  12. Lima MC, Paranhos A Jr, Salim S. Visually signifi cant cystoid macular edema in pseudophakic and aphakic patients with glaucoma receiving latanoprost. J Glaucoma 2000; 9: 317–21
  13. Halpern DL, Pasquale LR. Cystoid macular edema in aphakia and pseudophakia after use of PG analogs. Semin Ophthalmol. 2002; 17: 181–6
  14. Yeh PC, Ramanathan S. Latanoprost and clinically signifi cant cystoid macular edema after uneventful phacoemulsifi cation with intraocular lens implantation. J Cataract Refract Surg 2002; 28: 1814–8, 15. Kruse P, Rieck P, Sherif Z, Liekfeld A. Cystoid macular edema in a pseudophakic patient after several glaucoma procedures. Is local the